Good point. I think the French are the only ones that develop any decent pharmaceuticals outside the U.S. One of the most successful French pharmaceuticals is Tianeptine.
It's sort of a French Prozac but with a number of unique benefits that Prozac doesn't have. It's approved in several European countries but NOT in the U.K, and is only available in the U.S on the imported pharmaceutical grey market. Once it goes out of patent, and if it has not been approved for use in the U.S, it will NEVER be approved, ever, for any use in the U.S. That's because nobody would pay the 100s of millions of dollars to approve a drug that a competitor can produce as a generic.
http://en.wikipedia.org/wiki/Tianeptine
It's sort of a French Prozac but with a number of unique benefits that Prozac doesn't have. It's approved in several European countries but NOT in the U.K, and is only available in the U.S on the imported pharmaceutical grey market. Once it goes out of patent, and if it has not been approved for use in the U.S, it will NEVER be approved, ever, for any use in the U.S. That's because nobody would pay the 100s of millions of dollars to approve a drug that a competitor can produce as a generic.